These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8230303)
61. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
62. Metabolic polymorphisms and cancer susceptibility. Smith G; Stanley LA; Sim E; Strange RC; Wolf CR Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512 [TBL] [Abstract][Full Text] [Related]
63. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
66. Chemistry and biology of heme. Effect of metal salts, organometals, and metalloporphyrins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450. Beri R; Chandra R Drug Metab Rev; 1993; 25(1-2):49-152. PubMed ID: 8449148 [TBL] [Abstract][Full Text] [Related]
67. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related]
68. [Expression of cytochrome P-450 genes]. Lutz W Postepy Hig Med Dosw; 1992; 46(1):1-20. PubMed ID: 1641372 [TBL] [Abstract][Full Text] [Related]
69. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes]. Ozawa S Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514 [TBL] [Abstract][Full Text] [Related]
70. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. Lieber CS Alcohol Clin Exp Res; 1999 Jun; 23(6):991-1007. PubMed ID: 10397283 [TBL] [Abstract][Full Text] [Related]
71. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Cruzan G; Bus J; Banton M; Gingell R; Carlson G Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367 [TBL] [Abstract][Full Text] [Related]
73. Advances in mechanisms of activation and deactivation of environmental chemicals. Goldstein JA; Faletto MB Environ Health Perspect; 1993 Apr; 100():169-76. PubMed ID: 8354165 [TBL] [Abstract][Full Text] [Related]
75. DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. Gonzalez FJ; Crespi CL; Gelboin HV Mutat Res; 1991 Mar; 247(1):113-27. PubMed ID: 2002797 [TBL] [Abstract][Full Text] [Related]
77. Human cytochrome P-450 enzymes. Guengerich FP Life Sci; 1992; 50(20):1471-8. PubMed ID: 1579042 [TBL] [Abstract][Full Text] [Related]
78. Possible role of cytochromes P450 in lupus erythematosus and related disorders. McKinnon RA; Nebert DW Lupus; 1994 Dec; 3(6):473-8. PubMed ID: 7704004 [TBL] [Abstract][Full Text] [Related]
79. Protein engineering in studies on metabolism of toxic substances. Imai Y J Toxicol Sci; 1988 Nov; 13(4):290-5. PubMed ID: 3072426 [TBL] [Abstract][Full Text] [Related]
80. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Nebert DW; Ingelman-Sundberg M; Daly AK Drug Metab Rev; 1999 May; 31(2):467-87. PubMed ID: 10335448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]